Stroke care has seen considerable advances in recent years, and Stryker Neurovascular has played a role in these developments. In addition to expanding its portfolio to include cutting-edge products designed to remove blood clots in the brain quickly and efficiently, the company has one of the longest-running fellows programmes in the industry, and its investments in clinical trials have led to meaningful changes in stroke treatment guidelines.
In this educational supplement, Stryker outlines its full portfolio, detailing the evolution of the company’s Target Detachable Coil and the Surpass Evolve Flow Diverter for the treatment of haemorrhagic stroke, while also exhibiting its full range of stroke care solutions.
